Rilexine, 150 mg/ml, süstesuspensioon veistele
Rilexine, 150 mg/ml, süstesuspensioon veistele
Authorised
- Cefalexin
Product identification
Medicine name:
Rilexine, 150 mg/ml, süstesuspensioon veistele
Active substance:
- Cefalexin
Target species:
-
Cattle
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Cefalexin150.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Cattle
-
Meat and offal5day
-
Milk0dayMitte kasutada piima inimtoiduks ravi ajal.
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01DB01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Estonia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- VIRBAC
Responsible authority:
- State Agency Of Medicines
Authorisation number:
- 1403
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 14/01/2022
How useful was this page?:
